SEVEN EIGHT CAPITAL, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,194,111
-7.2%
57,299
+6.7%
0.14%
-34.3%
Q2 2023$1,286,690
+191.8%
53,724
+99.5%
0.21%
+142.0%
Q3 2022$441,000
+66.4%
26,935
+146.6%
0.09%
+151.4%
Q1 2022$265,000
+22.1%
10,923
+107.7%
0.04%
-25.5%
Q3 2020$217,000
-55.1%
5,258
-47.3%
0.05%
-86.7%
Q2 2020$483,000
-87.9%
9,968
-89.3%
0.35%
+67.3%
Q4 2019$3,983,000
-19.5%
93,099
-32.3%
0.21%
-19.2%
Q3 2019$4,948,000
+555.4%
137,469
+386.7%
0.26%
+552.5%
Q2 2019$755,000
+254.5%
28,244
+255.5%
0.04%
+263.6%
Q1 2019$213,000
-84.0%
7,944
-77.6%
0.01%
-93.3%
Q3 2017$1,334,000
+13240.0%
35,403
+11941.8%
0.16%
+8050.0%
Q1 2017$10,000
-96.9%
294
-97.3%
0.00%
-96.9%
Q4 2016$320,000
-37.6%
11,094
-23.0%
0.06%
-81.7%
Q4 2015$513,000
+288.6%
14,400
+260.0%
0.35%
+203.5%
Q3 2015$132,000
-62.2%
4,000
-63.6%
0.12%
-80.2%
Q4 2014$349,00011,0000.58%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders